Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue Sarcoma. A Multicenter Open-label Single Arm Phase Ib/IIa Trial

NCT03524898 is registered in ClinicalTrials.gov with Swiss Cancer Institute as lead sponsor.

NCT NCT03524898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03524898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue Sarcoma. A Multicenter Open-label Single Arm Phase Ib/IIa Trial
Lead sponsor
Swiss Cancer Institute
Phase
Phase 1/2
Overall status
Terminated
Start date
October 2, 2018
Completion date
February 15, 2022
Enrollment
39 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

soft tissue sarcoma